ZyVersa Therapeutics (ZVSA) Cash from Operations (2022 - 2026)
ZyVersa Therapeutics' Cash from Operations was -$800,000 in Q1 2026, compared with -$1.77 million a year earlier.
Powered by 
Analysis
ZyVersa Therapeutics (ZVSA) Cash from Operations (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, ZyVersa Therapeutics' Cash from Operations was -$4.14 million through Mar 31, 2026; for FY2025, it came in at -$5.11 million.
- In earlier years, Cash from Operations was -$7.52 million in FY2024, -$8.72 million in FY2023 and -$1.49 million in FY2022.
- Quarterly Cash from Operations has moved between -$4.59 million (Q1 2023) and -$98,165 (Q1 2022) over five years.
- Per Business Quant data, ZVSA's Cash from Operations in the three quarters before Q1 2026 was -$413,689 (Q4 2025), -$1.4 million (Q3 2025) and -$1.53 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 8.62 Bn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 835.00 Mn |
| 10 | ZyVersa Therapeutics | 404,796.06 | -599,719.94 | - | -800,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -800,000.00 |
| Dec 31, 2025 | -413,689.00 |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.53 Mn |
| Mar 31, 2025 | -1.77 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -614,141.00 |
| Jun 30, 2024 | -1.91 Mn |
| Mar 31, 2024 | -3.78 Mn |
| Dec 31, 2023 | -2.79 Mn |
| Sep 30, 2023 | -936,395.00 |
| Jun 30, 2023 | -407,620.00 |
| Mar 31, 2023 | -4.59 Mn |
| Jun 30, 2022 | -490,185.00 |
| Mar 31, 2022 | -98,165.00 |
API Access
ZyVersa Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ZVSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "ZVSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ZVSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();